A Prospective, Multi-center, Observational Study on the Efficacy and Safety of FEXUCLUE Tab. In Patients With Acute or Chronic Gastritis
Status: Recruiting
Location: See location...
Study Type: Observational
SUMMARY
This study aims to evaluate the efficacy of Fexuclue tablets in improving gastrointestinal symptoms based on patient-reported outcomes (PROs), by comparing assessments before and after treatment.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 19
Maximum Age: 75
Healthy Volunteers: f
View:
• Adult subjects between the ages of 19 and 75 years at the time of obtaining written informed consent.
• Subjects who are scheduled to receive Fexuclu tablets (fexuprazan) in accordance with the approved indication.
• Subjects who present with at least one subjective symptom requiring medical treatment
• Subjects who are capable of understanding the information provided, have voluntarily decided to participate in this observational study, and have provided written informed consent for the use of their personal data.
Locations
Other Locations
Republic of Korea
Masong Kim Internal Medicine Clinic
RECRUITING
Seoul
Contact Information
Primary
So Heui Kim
2210325@daewoong.co.kr
82-10-2994-5887
Time Frame
Start Date: 2025-06-17
Estimated Completion Date: 2027-06-03
Participants
Target number of participants: 12000
Treatments
Fexuclue® Tab
Fexuclue® Tab Fexuclue® Tab Fexuprazan Hydrochloride 10mg
Related Therapeutic Areas
Sponsors
Leads: Daewoong Pharmaceutical Co. LTD.